<DOC>
	<DOCNO>NCT01120301</DOCNO>
	<brief_summary>The purpose pivotal study demonstrate safety efficacy transcranial laser therapy ( TLT ) NeuroTheraÂ® Laser System treatment subject diagnose acute ischemic stroke . The initiation TLT procedure must feasible subject 4.5 24 hour stroke onset .</brief_summary>
	<brief_title>Efficacy Safety Trial Transcranial Laser Therapy Within 24 Hours From Stroke Onset ( NEST-3 )</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>1 . Clinical diagnosis acute ischemic stroke 2 . Subject candidate treatment neurothrombectomy 3 . Initiation TLT procedure begin 4.5 24 hour 4 . Baseline NIHSS score range : 717 5 . Full functional independence prior present stroke episode 6 . Negative pregnancy test female childbearing potential 7 . Subject Informed Consent obtain prior enrollment study 1 . Evidence intracranial , subdural , subarachnoid hemorrhage 2 . Acute ischemic stroke locate exclusively brainstem , cerebellum , small deep infarction , massive hemispheric stroke 3 . Seizure stroke onset within 7 day prior stroke onset 4 . Sustained blood glucose &gt; 300 &lt; 60 mg/dl 5 . Sustained hypertension ( SBP &gt; 220 mmHg DBP &gt; 140 mmHg ) 6 . Sustained hypotension ( SBP &lt; 80 mmHg DBP &lt; 50 mmHg ) 7 . A presumed and/or confirm septic embolus 8 . History CNS vascular disease ( e.g . aneurysm , AVM ) history CNS disease damage ( e.g . neoplasm dementia ) may influence subject 's outcome assessment . 9 . Head implant kind 10 . Significant skin condition scalp ( eg . psoriasis ) 11 . Use intravenous intraarterial thrombolytic medication 12 . Use diagnostic therapeutic interventional neurovascular procedure 13 . Female pregnant lactate childbearing potential use medically acceptable method birth control .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>stroke</keyword>
</DOC>